title: Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning.
authors.forename: Christoph
authors.initials: C
authors.lastname: Jochum
authors.forename: Mechthild
authors.initials: M
authors.lastname: Beste
authors.forename: Eustacia
authors.initials: E
authors.lastname: Zellmer
authors.forename: Scott S
authors.initials: SS
authors.lastname: Graves
authors.forename: Rainer
authors.initials: R
authors.lastname: Storb
authors.forename: Rainer
authors.initials: R
authors.lastname: Storb
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D006085:Graft Survival / Q000528:radiation effects*; D006086:Graft vs Host Disease / Q000517:prevention & control; D015395:Histocompatibility Antigens Class I; D017708:Leukocyte Transfusion; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods; D014916:Whole-Body Irradiation / Q000379:methods
chemical_list: D015395:Histocompatibility Antigens Class I